B. Pisarski, C. Wawrzen´czyk / Tetrahedron Letters 47 (2006) 6875–6877
6877
2.37 (1H, dd, J = 17.3 and 10.1, one of H-3), 2.27–2.47
(1H, m, H-4), 2.66 (1H, dd, J = 17.3 and 8.3, one of H-3),
3.27, 3.34 (2H, 2 · d, J = 11.1, CH2I); 13C NMR
(151 MHz, CDCl3): d 9.4, 12.9, 22.1, 27.3, 34.8, 46.5,
84.9, 174.8; diastereoisomer b, 1H NMR (300 MHz,
CDCl3); d 0.95 (3H, t, J = 7.3, CH3CH2), 1.29–1.70 (2H,
m, CH3CH2), 1.42 (3H, s, CH3), 2.28 (1H, dd, J = 16.8
and 10.1, one of H-3), 2.27–2.47 (1H, m, H-4), 2.73 (1H,
dd, J = 16.8 and 8.0, one of H-3), 3.36, 3.46 (2H, 2 · d,
J = 11.1, CH2I); 13C NMR (150 MHz, CDCl3): d 12.7,
14.4, 20.7, 23.4, 35.0, 45.0, 85.1, 174.3; IR (film, cmÀ1):
1775 (s), 1382 (m), 1255 (s), 1160 (s), 957 (s); Anal. Calcd
for C8H13IO2: C, 35.84; H, 4.89. Found: C, 36.27; H, 5.13.
14. Data for 5: crystals, mp 110–113 ꢁC; 1H NMR (600 MHz,
CDCl3): d 1.01; 1.17 (6H, two s, (CH3)2C), 1.19 (3H, s,
CH3-6), 1.36 (1H, d, J = 14.9, one of CH2-5), 1.70 (1H,
dd, J = 14.9 and 2.2, one of CH2-5), 1.79 (1H, dd, J = 13.8
and 13.2, H-3 axial), 2.02 (1H, ddd, J = 13.8, 4.1 and 2.2,
H-3 equatorial), 2.13; 2.76 (2H, 2 · d, J = 17.5, CH2-7),
4.02 (1H, ddd, J = 13.2, 9.2 and 4.1, H-2), 4.22 (1H, d,
J = 9.2, H-1); 13C NMR (150 MHz, CDCl3): d 26.8, 30.7,
33.3, 33.5, 40.5, 40.9, 45.2, 46.4, 49.4, 90.8, 175.2; IR (KBr,
cmÀ1): 1784 (s), 1454 (m), 1143 (s), 1024 (s), 989 (s), 696
(m); Anal. Calcd for C11H17BrO2: C, 50.59; H, 6.56.
Found: C, 50.56; H, 6.87.
is, in the presence of water, converted into trialkoxy-
hydroxyphosphonate (B). This unstable compound is
converted into the corresponding lactone and trialkyl
phosphate or its products of hydrolysis. Further studies
on the mechanism of this reaction and its wider applica-
tion are in progress.
References and notes
´
1. Fajkowska, M.; Obara, R.; Wawrzenczyk C. Biocatal.
Biotransform., submitted for publication.
2. Ranganathan, S.; Muraleedharan, K. M.; Vaish, N. K.;
Jayaraman, N. Tetrahedron 2004, 60, 5273–5308.
3. French, A. N.; Bissmire, S.; Wirth, T. Chem. Soc. Rev.
2004, 33, 354–362.
´
4. Paruch, E.; Ciunik, Z.; Nawrot, J.; Wawrzenczyk, C.
J. Agric. Food. Chem. 2000, 48, 4973–4977.
´
5. Lochynski, S.; Fra˛ckowiak, B.; Olejniczak, T.; Ciunik, Z.;
´
Wawrzenczyk, C. Tetrahedron: Asymmetry 2002, 13,
1761–1767.
´
´
6. Dams, I.; Białonska, A.; Ciunik, Z.; Wawrzenczyk, C.
J. Agric. Food Chem. 2004, 52, 1630–1634.
´
7. Grabarczyk, M.; Szumny, A.; Gładkowski, W.; Białonska,
´
15. Data for 6: crystals, mp 97–98 ꢁC, 1H NMR (600 MHz,
CDCl3): d 1.07, 1.12 (6H, two s, (CH3)2C), 1.26 (3H, s,
CH3-6), 1.40 (1H, d, J = 15.0, one of CH2-5), 1.69 (1H,
dd, J = 13.7 and 12.6, axial H-3), 1.70 (1H, dd, J = 15.0
and 2.2, one of CH2-5), 1.95 (1H, ddd, J = 13.7, 4.1 and
2.2, equatorial H-3), 2.20; 2.60 (2H, 2 · d, J = 17.5, CH2-
7), 4.02 (1H, ddd, J = 12.6, 8.7 and 4.1, H-2), 4.14 (1H, d,
J = 8.7, H-1); 13C NMR (150 MHz, CDCl3): d 26.8, 30.5,
32.4, 33.4, 40.6, 41.1, 45.2, 45.3, 58.3, 90.4, 175.3; IR (KBr,
cmÀ1): 1786 (s), 1455 (m), 1157 (s), 991 (m), 742 (m); Anal.
Calcd for C11H17ClO2: C, 60.97; H, 7.91. Found: C, 61.08;
H, 7.98.
Z.; Ciunik, A.; Wawrzenczyk, C. Pol. J. Chem. 2005, 79,
1763–1771.
8. Mateos, A. F.; Teresa, J. P.; Gonzales, R. R. J. Chem.
Soc., Perkin Trans. 1 1990, 2429–2435.
9. McNeill, A. H.; Mortlock, S. V.; Pratt, R. M.;
Thomas, E. J. J. Chem. Soc., Perkin Trans. 1 1998,
709–715.
´
10. Pisarski, B.; Wawrzenczyk, C. Ann. Pol. Chem. Soc. 2005,
1, 133–136.
´
´
11. Szumny, A.; Wawrzenczyk, C.; Gabrys, B.; Szczepanik,
M. Polish Patent Appl. PL-371908, 2004; Bull. Polish
Patent Office 2005, 12, 821.
_
12. Obara, R.; Szumny, A.; Zołnierczyk, Z.; Olejniczak, T.;
16. Okano, M. Bull. Chem. Soc. Jpn. 1976, 49, 1041–1046.
17. Barton, P. H. R.; Jang, D. O.; Jaszberenyi, J. C.
Tetrahedron Lett. 1992, 33, 2311–2314.
´
´
Białonska, A.; Ciunik, Z.; Wawrzenczyk, C. Pol. J. Chem.
2005, 79, 981–993.
18. Barton, H. R.; Jang, D. O.; Jaszberenyi, J. C. J. Org.
Chem. 1993, 58, 6838–6842.
19. Hirao, T.; Hirano, K.; Hasegawa, T.; Ohshiro, Y.; Ikeda,
I. J. Org. Chem. 1993, 58, 6529–6530.
13. Data for 1: oil, diastereoisomeric mixture (62% of diaste-
reoisomer a and 38% of diastereoisomer b): diastereoiso-
mer a, 1H NMR (300 MHz, CDCl3): d 0.97 (3H, t, J = 7.3,
CH3CH2), 1.29–1.70 (2H, m, CH3CH2), 1.57 (3H, s, CH3),